Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Stroke 1Squamous Cell Carcinoma of Head and Neck 1Sleep Initiation and Maintenance Disorders 1Pulmonary Disease, Chronic Obstructive 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Obesity, Abdominal 1Neoplasms 1Mouth Neoplasms 1Lung Neoplasms 1Laryngeal Neoplasms 1Kidney Failure, Chronic 1Hypopharyngeal Neoplasms 1Hematologic Neoplasms 1Head and Neck Carcinoma 1Diabetes Mellitus 1Delirium 1Coronary Artery Disease 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma 1COVID-19 1Advanced Breast Adenocarcinoma 1

Interventions

Temozolomide 6Methotrexate 5Radiotherapy 4Carboplatin 4Magnetic Resonance Spectroscopy 3Vincristine 2Thiotepa 2Specimen Handling 2Procarbazine 2Nivolumab 2Filgrastim 2Carmustine 2Bevacizumab 2sodium thiosulfate 1selinexor 1sargramostim 1motexafin gadolinium 1irinotecan sucrosofate 1infigratinib 1fluoroacetic acid 1Trastuzumab 1Topotecan 1Standard of Care 1Rituximab 1Radiation 1RG7388 1Psychiatric Rehabilitation 1Practice Guidelines as Topic 1Peripheral Blood Stem Cell Transplantation 1Oxaloacetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Central Nervous System Neoplasms × Practice Guidelines as Topic × Clear all
NCT05720624 2025-10-22

Pharmacodynamic Analyses of Metabolic Agents Following Brain Radiation

Mayo Clinic

Phase 1 Withdrawn
CNS

Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡